Healthcare provider profile · identity verified

Hanadi M. Farrukh, MD

Internal Medicine · SALT LAKE CITY, UT · NPI 1043300643

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	507	143
Omeprazole	Omeprazole	423	122
Levothyroxine Sodium	Levothyroxine Sodium	396	98
Losartan Potassium	Losartan Potassium	334	93
Rosuvastatin Calcium	Rosuvastatin Calcium	287	95
Amlodipine Besylate	Amlodipine Besylate	271	84
Lisinopril	Lisinopril	230	62
Gabapentin	Gabapentin	224	57
Metformin Hcl	Metformin Hcl	213	55
Eliquis	Apixaban	173	32
Fluticasone Propionate	Fluticasone Propionate	150	63
Alendronate Sodium	Alendronate Sodium	141	46
Buspirone Hcl	Buspirone Hcl	130	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	122	32
Pravastatin Sodium	Pravastatin Sodium	121	34
Potassium Chloride	Potassium Chloride	118	40
Tamsulosin Hcl	Tamsulosin Hcl	115	35
Duloxetine Hcl	Duloxetine Hcl	110	28
Trazodone Hcl	Trazodone Hcl	109	32
Furosemide	Furosemide	106	36
Zolpidem Tartrate	Zolpidem Tartrate	93	31
Escitalopram Oxalate	Escitalopram Oxalate	92	27
Metoprolol Succinate	Metoprolol Succinate	91	28
Estradiol	Estradiol	87	28
Sertraline Hcl	Sertraline Hcl	86	28
Hydrochlorothiazide	Hydrochlorothiazide	81	22
Carvedilol	Carvedilol	78	24
Citalopram Hbr	Citalopram Hydrobromide	77	21
Fluoxetine Hcl	Fluoxetine Hcl	77	22
Metformin Hcl Er	Metformin Hcl	76	24
Pantoprazole Sodium	Pantoprazole Sodium	71	22
Tramadol Hcl	Tramadol Hcl	70	18
Spironolactone	Spironolactone	69	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	14
Simvastatin	Simvastatin	68	18
Allopurinol	Allopurinol	67	18
Donepezil Hcl	Donepezil Hcl	65	19
Famotidine	Famotidine	65	25
Oxybutynin Chloride Er	Oxybutynin Chloride	63	15
Albuterol Sulfate Hfa	Albuterol Sulfate	60	28
Ezetimibe	Ezetimibe	59	21
Bupropion Xl	Bupropion Hcl	58	17
Farxiga	Dapagliflozin Propanediol	54	12
Valacyclovir	Valacyclovir Hcl	53	17
Alprazolam	Alprazolam	52	11
Celecoxib	Celecoxib	52	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	14
Meloxicam	Meloxicam	51	22
Montelukast Sodium	Montelukast Sodium	51	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	19
Memantine Hcl	Memantine Hcl	50	12
Clonazepam	Clonazepam	49	13
Januvia	Sitagliptin Phosphate	49	13
Oxycodone Hcl	Oxycodone Hcl	47	suppressed
Mounjaro	Tirzepatide	46	suppressed
Pregabalin	Pregabalin	45	suppressed
Jardiance	Empagliflozin	44	suppressed
Diclofenac Sodium	Diclofenac Sodium	42	20
Myrbetriq	Mirabegron	42	12
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Ozempic	Semaglutide	36	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	36	12
Synthroid	Levothyroxine Sodium	36	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	suppressed
Finasteride	Finasteride	35	12
Modafinil	Modafinil	35	suppressed
Mirtazapine	Mirtazapine	34	12
Ibuprofen	Ibuprofen	33	13
Lorazepam	Lorazepam	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	20
Ondansetron Hcl	Ondansetron Hcl	32	19
Diazepam	Diazepam	31	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Xarelto	Rivaroxaban	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	22
Sumatriptan Succinate	Sumatriptan Succinate	27	11
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	15
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Nystatin	Nystatin	20	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	19	suppressed
Repatha Sureclick	Evolocumab	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	14
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Atenolol	Atenolol	17	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	17	suppressed
Minoxidil	Minoxidil	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Cefdinir	Cefdinir	16	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Primidone	Primidone	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Levofloxacin	Levofloxacin	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Progesterone	Progesterone, Micronized	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Prednisone	Prednisone	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error